TOFACITINIB | TOFACITINIB | ATC L04AA29
IMMUNOMODULATING INHIBITOR OF JANUS KINASES (JAKS) TREATMENT OF RHEUMATOID ARTHRITIS | ORAL | F 74 PERCENT VD 87 LITER PPB 40 PERCENT Cl 20 LITER / HOUR (EQN) HT 3 HOUR SOLUBILITY FREELY SOLUBLE IN WATER | JANUS KINASES (JAK) PDB 3LXK (STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 AND JAK3 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6) LIGAND CODE = MI1 (link to the list of PDB complexes) Download experimental 3D coordinates of MI1 with added hydrogens | JANUS KINASE (JAK) INHIBITOR CHEMBL2363062 JANUS KINASE (JAK) O60674 TYROSINE-PROTEIN KINASE JAK2 HOMO SAPIENS ENZYME KINASE PROTEIN KINASE TK JAKA | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |